Rami Ziv
Director/Board Member bei Qualitas Health Ltd.
Profil
Rami Ziv is currently a Director at Qualitas Health Ltd.
Prior to this, he was a Director at Shaniv Paper Industry Ltd.
from 2017 to 2022.
He obtained an undergraduate degree from Ruppin Academic Institute.
Aktive Positionen von Rami Ziv
Unternehmen | Position | Beginn |
---|---|---|
Qualitas Health Ltd.
Qualitas Health Ltd. Pharmaceuticals: OtherHealth Technology Part of Qualitas Health, Inc., Qualitas Health Ltd. is an Israeli company that offers algae omega-3 supplements to support better living, including cardiovascular health, a balanced mood, and healthy brain development. The private company is based in Jerusalem, Israel. The company's vegan brain supplement is a blend of their proprietary omega-3 and other powerful nutrients that act as cell protectors to improve brain health. The CEO of the company is Miguel Calatayud. | Director/Board Member | - |
Ehemalige bekannte Positionen von Rami Ziv
Unternehmen | Position | Ende |
---|---|---|
SHANIV PAPER INDUSTRY LTD | Director/Board Member | 29.12.2022 |
Ausbildung von Rami Ziv
Ruppin Academic Institute | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SHANIV PAPER INDUSTRY LTD | Consumer Non-Durables |
Private Unternehmen | 1 |
---|---|
Qualitas Health Ltd.
Qualitas Health Ltd. Pharmaceuticals: OtherHealth Technology Part of Qualitas Health, Inc., Qualitas Health Ltd. is an Israeli company that offers algae omega-3 supplements to support better living, including cardiovascular health, a balanced mood, and healthy brain development. The private company is based in Jerusalem, Israel. The company's vegan brain supplement is a blend of their proprietary omega-3 and other powerful nutrients that act as cell protectors to improve brain health. The CEO of the company is Miguel Calatayud. | Health Technology |